You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Ex Vivo Tolerance for Xenotransplantation of Diabetes P2
SBC: XIMEREX, INC. Topic: NIDDKDESCRIPTION (provided by applicant): Type I diabetes is a widespread disease in which insulin producing pancreatic islets are lost, leading to unstable glucose levels. If the islets can be replaced, as with transplantation, then diabetes can be reversed.Human islets have limited utility because of a severe shortage of donors and the need for constant immune suppression to prevent rejection. Pigs ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
RADIOGRAPHIC CONTRAST TO DIFFERENTIATE CAVITATED FROM NON-CAVITATED DENTAL CARIES
SBC: FIREFLY HEALTH INNOVATIONS NE, INC. Topic: NIDCRDESCRIPTION (provided by applicant): This project relates directly to the PHS 2011-2, Omnibus Solicitation for SBIR/STTR Grant Application page NIDCR 110: Development of instrumentation for early caries detection and comparison studies on specificity andselectivity with respect to current clinical practice. The proposed test is intended to enable dentists to differentiate between cavitated and ...
STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health -
Development of Ultrafine Particles for Intranasal Delivery of Antipsychotics
SBC: LNKCHEMSOLUTIONS Topic: NIMHDESCRIPTION: The goal of the proposed project is to develop a biocompatible ultrafine particle-based vector system for the intranasal delivery of clozapine for the pharmacological therapy of treatment- resistant schizophrenic disorders and their associatedsuicidal behavior. The rationale behind the use of intranasal clozapine is grounded on the observation of clozapine's extensive first- pass ...
STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health -
Early Detection of Pancreatic Cancer Using Ice COLD-PCR
SBC: TRANSGENOMIC, INC. Topic: NCATSDESCRIPTION (provided by applicant): Ninety percent of all pancreatic cancers are pancreatic ductal adenocarcinoma (PDAC). PDAC diagnosis is difficult, usually occurring in the late stages of disease. Patients with these advanced tumors typically respondpoorly to therapy. Post diagnosis, median survival is 6 months and the five-year survival rate is lt 4%. Five-year survival is lt 1% for those wi ...
STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health -
N/A
SBC: ACCURATE ASSESSMENTS Topic: N/AN/A
SBIR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health -
N/A
SBC: LI-COR BIOSCIENCES, INC. Topic: N/AN/A
SBIR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health -
N/A
SBC: LI-COR BIOSCIENCES, INC. Topic: N/AN/A
SBIR Phase II 2000 Department of Health and Human ServicesNational Institutes of Health -
N/A
SBC: LI-COR BIOSCIENCES, INC. Topic: N/AN/A
SBIR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health -
N/A
SBC: LI-COR BIOSCIENCES, INC. Topic: N/AN/A
SBIR Phase II 2000 Department of Health and Human ServicesNational Institutes of Health